CIP Web Site: http://cip.cancer.gov/
CANCER IMAGING PROGRAM is our new name.
5TH NATIONAL FORUM ON BIOMEDICAL IMAGING IN ONCOLOGY
January 29-30, 2004, Hyatt Regency Bethesda, Bethesda, MD
SPIE INTERNATIONAL SYMPOSIUM: MEDICAL IMAGING 2004
14 - 19 February 2004, Town & Country Hotel, San Diego, CA
2004 BIOMEDICAL IMAGING RESEARCH OPPORTUNITIES WORKSHOP (BIROW II) February 25-26, 2004, Bethesda Marriott Hotel, Bethesda, MD. This workshop is the second in a series of five being organized by the AAPM, RSNA, BMES, ARR and AIMBE.
SOCIETY OF INTERVENTIONAL RADIOLOGY 29th Annual Scientific Meeting
Phoenix Civic Plaza, Phoenix, Arizona, March 25 - 30, 2004
ACADEMY OF MOLECULAR IMAGING ANNUAL MEETING
2004 AMI Annual Conference, to be held March 28-31, 2004, at the Gaylord Palms Resort and Convention Center in Orlando, Florida.
CANCER IMAGING 2004: MR, CT & PET
May 23-25, 2004, Sheraton Chicago Hotel & Towers, Chicago, Illinois
SOCIETY OF NUCLEAR MEDICINE 51st ANNUAL MEETING
June 19-23, 2004, Pennsylvania Convention Center, Philadelphia, PA.
BECON/BISTIC SYMPOSIUM: Informatics for Clinical Decision-making in the 21st Century
June 21-22, 2004, Natcher Auditorium, NIH Campus, Bethesda, MD
CARS 2004 COMPUTER ASSISTED RADIOLOGY AND SURGERY
June 23-26, 2004, Hilton & Towers Hotel, Chicago, IL, USA
SEVENTEENTH IEEE SYMPOSIUM ON COMPUTER BASED MEDICAL SYSTEMS (CBMS 2004) June 24-25, 2004, Hotel Four Points by Sheraton, Bethesda, Maryland
FIRST INTERNATIONAL SYMPOSIUM ON CANCER METASTASIS AND THE LYMPHOVASCULAR SYSTEM: THE BASIS FOR RATIONAL THERAPY
July 8-10, 2004, San Francisco, CA, USA
THIRD ANNUAL MEETING OF THE SOCIETY FOR MOLECULAR IMAGING
September 9-12, 2004, Adam's Mark Hotel, St. Louis, MO
INTERAGENCY COUNCIL ON BIOMEDICAL IMAGING IN ONCOLOGY (ICBIO)
Next Due Date for Requests - February 10 (for March 23 meeting)
The ICBIO convenes technology developers and representatives from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid (CMS) to expedite the process of bringing new products to market, to provide advice from a multi-agency perspective on the spectrum of scientific, regulatory, and reimbursement issues related to developing your imaging device or technology. The Request to Present form and further information can be found at http://cancer.gov/dctd/icbio
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof?of?principle clinical trials. See the web site for details.
The NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Applicants and grants administrators should become familiar with the Commons.
1. NIH ROADMAP
The NIH Roadmap is an integrated vision to deepen our understanding of biology, stimulate interdisciplinary research teams, and reshape clinical research to accelerate medical discovery and improve people's health. Most of the initiatives will begin in FY 2004. Other initiatives will start in FY 2005 and beyond, depending upon the budget and other emerging needs. The three NIH Roadmap themes are as follows: new pathways to discovery, research teams of the future, and re-engineering the clinical research Enterprise.
2. INTEGRATIVE CANCER BIOLOGY PROGRAMS (NCI) (CA-04-013)
LETTER OF INTENT RECEIPT DATE: February 13, 2004
APPLICATION RECEIPT DATE: April 13, 2004
The goal of this initiative is to promote the analysis of cancer as a complex biological system, by supporting the development of reliably predictive in silico or computational models of cancer initiation and progression that can ultimately lead to the development of improved cancer interventions. This initiative is intended to facilitate the establishment of research programs in integrative cancer biology, which bring together cancer biologists and scientists from fields such as mathematics, physics, information technology, imaging sciences, and computer science to work on a common cancer biology problem. See below for informational meeting information.
ORIENTATION MEETING FOR NCI INTEGRATIVE CANCER BIOLOGY PROGRAM RFA (CA-04-013) (NOT-CA-04-005)
January 26, 2004, Bethesda Marriott, Bethesda, MD
Web site for the Meeting Information: http://dcb.nci.nih.gov/branchdetail.cfm?branch=1
3. INNOVATIVE TECHNOLOGIES FOR MOLECULAR ANALYSIS OF CANCER (NCI)
This initiative capitalizes on both the success and intent of the original NCI sponsored Innovative Molecular Analysis Technologies (IMAT) program in bringing together a multi-disciplinary group of scientists and engineers to work on cancer and the expansion of interest in technology development across the NCI and other NIH institutes. This continuation of the IMAT program consists of the following three initiatives:
Projects focused on the development of novel technologies may be most suitable for RFA CA-05-002, Innovative Technologies for the Molecular Analysis of Cancer
). Projects focused on evaluating emerging technologies that are ready for initial clinical or biological application in cancer research may be most suitable for RFA CA-05-003, Application of Emerging Technologies for Cancer Research (http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-003.html).
Technologies developed or adapted for sample preparation methodology may be most suitable for RFA CA-05-004, Innovations in Cancer Sample Preparation
For small businesses, there will be a series of SBIR announcements; consult http://cancer.gov/otir
and the NIH Guide at http://grants1.nih.gov/grants/guide/index.html
4. NCRR SHARED INSTRUMENTATION GRANT (SIG) PROGRAM (NCRR) (PAR-04-029)
APPLICATION RECEIPT DATE: March 19, 2004
The objective is to make available to institutions expensive research instruments that can only be justified on a shared-use basis and for which meritorious research projects are described. The SIG Program provides a cost-effective mechanism for groups of NIH-supported investigators to obtain commercially-available, technologically sophisticated equipment costing more than $100,000.
5. NIGMS: MULTIDISCIPLINARY CONFERENCE GRANTS (NOT-GM-04-106)
The purpose of this notice is to encourage the submission of conference grant (R13) and cooperative agreement (U13) applications seeking funding for the support of new multidisciplinary scientific meetings, under the NIH Program Announcement, "NIH Support for Conferences and Scientific Meetings."
6. COLORECTAL CANCER SCREENING IN PRIMARY CARE PRACTICE (AHRQ, NCI) (PAR-04-036)
Primary care practice is an important point of entry for colorectal cancer screening. The NCI and Agency for Healthcare Research and Quality are interested in promoting research to improve colorectal cancer screening delivery, utilization, and outcomes in primary care practice. The objective of this Program Announcement is to encourage health services, social and behavioral, and outcomes researchers to develop innovative research projects to increase the knowledge base for enhanced translation of effective colorectal cancer screening techniques into community practice. Both R21 and R01 projects will be supported by this program.
7. GERRAF FELLOWSHIPS
Application Deadline: January 23, 2004
GE Medical Systems (GE) and the Association of University Radiologists (AUR) announce that nominations for the 2004 GE-AUR Radiology Research Academic Fellowships (GERRAF) are now being accepted. Selected recipients will receive 2-year GERRAF awards effective with the academic year beginning July 2004.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (email@example.com
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507